MedTrace Logo

Proactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19

NCT04322396 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 117

Last updated 2021-06-29

Study results available
· View outcomes & findings →

Summary

This study explores whether patients acutely hospitalized may have shorter hospitalization and fewer admittances at Intensive Care Units by treatment with azithromycin and hydroxychloroquine.

Conditions

  • Virus Diseases
  • Infection Viral
  • Corona Virus Infection

Interventions

DRUG

Azithromycin

Azithromycin

DRUG

Hydroxychloroquine

Hydroxychloroquine

DRUG

Placebo oral tablet

Placebo Azithromycin

DRUG

Placebo oral tablet

Placebo Hydroxychloroquine

Sponsors & Collaborators

  • Chronic Obstructive Pulmonary Disease Trial Network, Denmark

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-06
Primary Completion
2021-02-02
Completion
2021-02-02

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04322396 on ClinicalTrials.gov